Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Moore

Showing results (1401-1410 of 1,421) with videos related to

Pageof 143
Sort By:
Biorxiv : the Preprint Server for Biology|June 2, 2021
Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman PrimatesKizzmekia S Corbett, Anne P Werner, Sarah O' Connell, et al.
Nature Immunology|August 21, 2021
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primatesKizzmekia S Corbett, Anne P Werner, Sarah O' Connell, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman PrimatesJoseph R Francica, Barbara J Flynn, Kathryn E Foulds, et al.
Science (New York, N.Y.)|September 16, 2021
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primatesKizzmekia S Corbett, Martha C Nason, Britta Flach, et al.
Biorxiv : the Preprint Server for Biology|August 24, 2021
Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman PrimatesKizzmekia S Corbett, Matthew Gagne, Danielle A Wagner, et al.
Science Translational Medicine|July 28, 2021
Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primatesJoseph R Francica, Barbara J Flynn, Kathryn E Foulds, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen PreparednessKizzmekia S Corbett, Darin Edwards, Sarah R Leist, et al.
Cell|July 9, 2021
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodiesDapeng Li, Robert J Edwards, Kartik Manne, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primatesDapeng Li, Robert J Edwards, Kartik Manne, et al.
Nature|August 7, 2020
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparednessKizzmekia S Corbett, Darin K Edwards, Sarah R Leist, et al.
Pageof 143

Showing results (1401-1410 of 1,421) with videos related to

Sort By:
Pageof 143
Biorxiv : the Preprint Server for Biology|June 2, 2021
Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman PrimatesKizzmekia S Corbett, Anne P Werner, Sarah O' Connell, et al.
Nature Immunology|August 21, 2021
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primatesKizzmekia S Corbett, Anne P Werner, Sarah O' Connell, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman PrimatesJoseph R Francica, Barbara J Flynn, Kathryn E Foulds, et al.
Science (New York, N.Y.)|September 16, 2021
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primatesKizzmekia S Corbett, Martha C Nason, Britta Flach, et al.
Biorxiv : the Preprint Server for Biology|August 24, 2021
Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman PrimatesKizzmekia S Corbett, Matthew Gagne, Danielle A Wagner, et al.
Science Translational Medicine|July 28, 2021
Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primatesJoseph R Francica, Barbara J Flynn, Kathryn E Foulds, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen PreparednessKizzmekia S Corbett, Darin Edwards, Sarah R Leist, et al.
Cell|July 9, 2021
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodiesDapeng Li, Robert J Edwards, Kartik Manne, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primatesDapeng Li, Robert J Edwards, Kartik Manne, et al.
Nature|August 7, 2020
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparednessKizzmekia S Corbett, Darin K Edwards, Sarah R Leist, et al.
Pageof 143